Skip to main content
. 2022 Apr 13;158(5):533–541. doi: 10.1001/jamadermatol.2022.0655

Figure 2. Proportion of Patients Achieving End Points and Observed and Imputed Response Rates.

Figure 2.

The numbers of responders at milestone intervals were as follows: Psoriasis Area and Severity Index (PASI) 90: 71 at week 12, 79 at week 48, 76 at week 60, and 74 at week 108; PASI 100: 44 at week 12, 51 at week 48, 50 at week 60, and 52 at week 108. NRI indicates nonresponder imputation; sPGA, static Physician’s Global Assessment.